Prospective study designed to assess the immunological effect of a specific B. infantis strain on the incidence of atopic dermatitis, one of the most prevalent pediatric allergic diseases.
As with adults, infants’ gut bacteria are less diverse than ever, which may play a role in disease progression later in life. C-sections and antibiotics may be partly to blame.
Former Infinant Health, Inc Board Member Mike Johnson will lead the company as it continues to spearhead innovative advancements in science surrounding infant health
Study Published in Journal of Pediatrics Discusses Potential for Improved Clinical Care Associated with Administration of B. infantis EVC001 in Very Low Birth Weight Infants
Study aims to investigate whether infant probiotic Evivo can reduce development of early childhood atopic dermatitis, which is implicated in asthma, allergic rhinitis and food allergies, and affects ...
